Zenith Drugs (NSE:ZENITHDRUG) GF Score: 36/100 (As of Jul. 20, 2026) — 112% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ZENITHDRUG Zenith Drugs Ltd NSE:ZENITHDRUG
36 GF Score
Price ₹51.00
! 8 Warning Signs
View Full Analysis

What is Zenith Drugs GF Score?

Zenith Drugs NSE:ZENITHDRUG +1.80% 36 GF Score is 36 as of Jul. 20, 2026, which is 112% above its 10-year median of 17.00. GuruFocus rates NSE:ZENITHDRUG with a GF Score™ of 36/100. The stock has 8 warning signs investors should review.

Zenith Drugs has the GF Score of 36, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 3/10
2. Profitability Rank : 7/10
3. Growth Rank : 8/10
4. GF Value Rank : 0/10
5. Momentum Rank : 0/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Zenith Drugs might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Zenith Drugs  (NSE:ZENITHDRUG) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Zenith Drugs GF Score Related Terms

NSE:ZENITHDRUG vs ZTS, UTHR: GF Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zenith Drugs's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zenith Drugs GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenith Drugs's GF Score distribution charts can be found below:

* The bar in red indicates where Zenith Drugs's GF Score falls into.


NSE:ZENITHDRUG
36GF Score
Zenith Drugs Ltd NSE:ZENITHDRUG
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 36 mean?
Zenith Drugs (NSE:ZENITHDRUG) has a GF Score of 36 as of Jul. 20, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Zenith Drugs and its competitors. This is 112% above median its historical median of 17.00. Over the past decade, Zenith Drugs' GF Score has ranged from 3.00 to 24.00.
Is Zenith Drugs' GF Score too high?
Zenith Drugs' current GF Score of 36 is 112% above median its 10-year median of 17.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 24.00. Overall, Zenith Drugs has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zenith Drugs' GF Score compare to ZTS and UTHR?
Zenith Drugs' GF Score of 36 can be compared against companies in the Drug Manufacturers industry. Historically, Zenith Drugs' own GF Score has ranged from 3.00 to 24.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Zenith Drugs and its competitors. Zenith Drugs's current GF Score is 36, which is 112% above median its own 10-year median of 17.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Drugs stock overvalued right now?
Zenith Drugs (NSE:ZENITHDRUG) has a current GF Score of 36. The current GF Score is 36, which is 112% above median its 10-year median of 17.00. Zenith Drugs' overall GF Score™ is 36/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Zenith Drugs (NSE:ZENITHDRUG), the current GF Score is 36 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zenith Drugs Business Description

Address K. No. 72/5, Village Muradpura, Depalpur, Indore, MP, IND, 453001
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, Creams, Gels, Capsules, and Tablets. It is also into Generic Medicines.
36GF Score

Get the complete analysis for NSE:ZENITHDRUG

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹51.00
Price